Pentacare Online Quiz April 2018

20 Questions | Attempts: 49
Share

SettingsSettingsSettings
Pentacare Online Quiz April 2018 - Quiz

PENTACARE ONLINE TEST APRIL 2018


Questions and Answers
  • 1. 

    Which one of the following is not a positive symptom of schizophrenia -

    • A.

      Hallucination

    • B.

      Delusion

    • C.

      Agression

    • D.

      Alogia

    Correct Answer
    D. Alogia
  • 2. 

    Anticholinergic side effects occur when a drug blocks M1 receptor and the symptoms are :-

    • A.

      Blurred Vision, Diarrhea , Dry Mouth and Urinary Retention

    • B.

      Blurred Vision, Constipation, Hypersalivation and Urinary Retention

    • C.

      Blurred Vision, Constipation, Dry Mouth and Urinary Retention

    • D.

      Blurred Vision, Diplopia, Constipation and Urinary Retention

    Correct Answer
    C. Blurred Vision, Constipation, Dry Mouth and Urinary Retention
  • 3. 

    _________ is a condition which can lead to the triggering of a pain response from stimuli which do not normally provoke pain and is a symptom of Fibromyalgia.

    • A.

      Hyperpathia

    • B.

      Allodynia

    • C.

      Hyperalgesia

    • D.

      None of the above

    Correct Answer
    B. Allodynia
  • 4. 

    Which are the common behavioral and psychological symptoms of Dementia :-

    • A.

      Repetitive Behaviour

    • B.

      Mood disturbances

    • C.

      Social Inappropriateness

    • D.

      Psychosis

    • E.

      All the above

    • F.

      All the above

    • G.

      All the above

    • H.

      All the above

    Correct Answer(s)
    E. All the above
    F. All the above
    G. All the above
    H. All the above
  • 5. 

    Parkinson's disease is a neurodegenerative disorder, which leads to progressive deterioration of motor function due to loss of ____________producing brain cells.

    • A.

      Dopamine

    • B.

      Serotonin

    • C.

      Acetylcholine

    • D.

      NE

    Correct Answer
    A. Dopamine
  • 6. 

    The objective for Donep is to increase prescribing neuros by a minimum of _________/ME/Qtr

    • A.

      5

    • B.

      3

    • C.

      7

    • D.

      10

    Correct Answer
    B. 3
  • 7. 

    Which of the following is a normal memory change :-

    • A.

      Get lost in familiar places and takes excessive time to return home

    • B.

      Loss of interest in social activities; may behave in socially inappropriate way

    • C.

      Frequent word-finding pauses ,substitutes

    • D.

      Occasionally searches for words

    Correct Answer
    D. Occasionally searches for words
  • 8. 

    MCI Stands for :-

    • A.

      Maximum Cognitive Impairment

    • B.

      Moderate Cognitive Impairment

    • C.

      Minimum Cognitive Impairment

    • D.

      Mild Cognitive Impairment

    Correct Answer
    D. Mild Cognitive Impairment
  • 9. 

    Which of the following molecule is showing highest growth among all AED :-

    • A.

      Levetiracetam

    • B.

      Clobazam

    • C.

      Lacosamide

    • D.

      Lamotrigine

    Correct Answer
    C. Lacosamide
  • 10. 

    Which of the following inputs are to be given for Sizlac :-

    • A.

      Relaunch Slider Box

    • B.

      5 in 1 highlighter

    • C.

      40 Units Tablet and 20 Injections

    • D.

      Product Monograph

    • E.

      All of the above

    Correct Answer
    E. All of the above
  • 11. 

    SIZLAC injection is a clear, colourless, sterile solution containing __________________lacosamide per ml for intravenous use. 5mg

    • A.

      5 MG

    • B.

      10 MG

    • C.

      15 MG

    • D.

      20 MG

    Correct Answer
    B. 10 MG
  • 12. 

    Seizgard is a brand of _________________.

    • A.

      INTAS

    • B.

      SUN

    • C.

      TORRENT

    • D.

      DR REDDYS

    Correct Answer
    D. DR REDDYS
  • 13. 

    Lacosamide is approved as monotherapy and adjunctive therapy in treatment of focal onset of seizure in children aging 4 to 16 years by _______________.

    • A.

      USFDA

    • B.

      AAN

    • C.

      EMA

    • D.

      EFNS

    Correct Answer
    C. EMA
  • 14. 

    Which of the following is true for the sample strategy of Melzap :-

    • A.

      To be distributed to 10Psy, 10CPs and 5 Neuros

    • B.

      No. of samples 6 Units to each doctor

    • C.

      150 Units of .25mg/ME/Month

    • D.

      All the above

    Correct Answer
    D. All the above
  • 15. 

    Key advantages of Melzap MD are :-

    • A.

      Smaller Tablet with least amount of excipients

    • B.

      Easy to take even without water due to MD formulation

    • C.

      Rapid disintegration time

    • D.

      Presence of super disintegrant (Crosscarmellose sodium)

    • E.

      All of the above

    Correct Answer
    E. All of the above
  • 16. 

    Neurokem add value campaign includes :-

    • A.

      Treatment

    • B.

      Diagnosis

    • C.

      In-clinic Activities

    • D.

      Academic Needs

    • E.

      All of the above

    Correct Answer
    E. All of the above
  • 17. 

    The punchline for Neurokem OD is :-

    • A.

      The Neuropathic Pain Specialists

    • B.

      Enhance the compliance

    • C.

      Controls Pain Protects Nerve

    • D.

      The Comprehensive solution

    Correct Answer
    B. Enhance the compliance
  • 18. 

    The composition of Neurokem Plus is :-

    • A.

      Pregabalin 75mg, Mecobalamin 750mcg, Folic acid 1.5 mg, Pyridoxine 3mg, Alpha Lipoic Acid 100mg

    • B.

      Pregabalin 150mg, Mecobalamin 750mcg, Folic acid 1.5 mg, Pyridoxine 3mg, Alpha Lipoic Acid 100mg

    • C.

      Pregabalin 75mg, Mecobalamin 750mcg, Folic acid 1.5 mg, Pyridoxine 3mg, Alpha Lipoic Acid 200mg

    • D.

      Pregabalin 75mg, Mecobalamin 750mcg, Folic acid 3 mg, Pyridoxine 1.5mg, Alpha Lipoic Acid 100mg

    Correct Answer
    A. Pregabalin 75mg, Mecobalamin 750mcg, Folic acid 1.5 mg, Pyridoxine 3mg, Alpha Lipoic Acid 100mg
  • 19. 

    Patient education VR-Box is to be used for which product :-

    • A.

      Neurokem

    • B.

      Ceham

    • C.

      Donep

    • D.

      Migrabeta

    Correct Answer
    A. Neurokem
  • 20. 

    What were the key take away from March Cycle Meeting for Ceham :-

    • A.

      Double up your productivity

    • B.

      Conversions of 5 New CP & 5 New Neuro

    • C.

      Focus on Rxns and there by built Rxber base

    • D.

      Priority brand from engagement Drs for ROI

    • E.

      All of the above

    Correct Answer
    E. All of the above

Quiz Review Timeline +

Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.

  • Current Version
  • Mar 15, 2022
    Quiz Edited by
    ProProfs Editorial Team
  • Apr 12, 2018
    Quiz Created by
    Sujit
Back to Top Back to top
Advertisement